Results for tag: "Aminopeptidase N"

Aminopeptidase N (APN) is a type of hematological drug used to treat a variety of blood disorders. It is a zinc-dependent metalloprotease that is involved in the metabolism of peptides and proteins. APN is used to treat conditions such as thrombocytopenia, anemia, and other hematological disorders. It is also used to treat certain types of cancer, including leukemia and lymphoma. APN is typically administered intravenously or subcutaneously. APN is a relatively new drug, and its use is still being studied. It is believed to have potential benefits in treating a variety of hematological disorders, including those caused by chemotherapy and radiation. Several companies are involved in the APN market, including Novartis, Pfizer, and Merck. These companies are researching and developing new treatments for hematological disorders using APN. Additionally, there are several smaller companies that are developing APN-based treatments for various hematological disorders. Show Less Read more